Two Sigma Investments’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,020
| Closed | -$2.51M | – | 3111 |
|
|
2025
Q1 | $2.51M | Sell |
62,020
-65,300
| -51% | -$2.64M | 0.01% | 1554 |
|
|
2024
Q4 | $3.54M | Buy |
127,320
+38,500
| +43% | +$1.07M | 0.01% | 1276 |
|
|
2024
Q3 | $2.55M | Sell |
88,820
-31,254
| -26% | -$897K | 0.01% | 1466 |
|
|
2024
Q2 | $2.82M | Buy |
120,074
+75,787
| +171% | +$1.78M | 0.01% | 1263 |
|
|
2024
Q1 | $1.12M | Buy |
+44,287
| New | +$1.12M | ﹤0.01% | 1824 |
|
|
2023
Q4 | – | Sell |
-33,800
| Closed | -$1.71M | – | 3033 |
|
|
2023
Q3 | $1.71M | Hold |
33,800
| – | – | ﹤0.01% | 1451 |
|
|
2023
Q2 | $1.58M | Sell |
33,800
-200
| -0.6% | -$9.34K | ﹤0.01% | 1573 |
|
|
2023
Q1 | $1.3M | Sell |
34,000
-8,322
| -20% | -$318K | ﹤0.01% | 1652 |
|
|
2022
Q4 | $2.32M | Sell |
42,322
-91,225
| -68% | -$5M | 0.01% | 1199 |
|
|
2022
Q3 | $4.55M | Buy |
133,547
+66,911
| +100% | +$2.28M | 0.02% | 769 |
|
|
2022
Q2 | $630K | Sell |
66,636
-10,424
| -14% | -$98.6K | ﹤0.01% | 1675 |
|
|
2022
Q1 | $1.09M | Buy |
77,060
+57,560
| +295% | +$816K | ﹤0.01% | 1635 |
|
|
2021
Q4 | $412K | Sell |
19,500
-61,471
| -76% | -$1.3M | ﹤0.01% | 2058 |
|
|
2021
Q3 | $1.81M | Sell |
80,971
-81,446
| -50% | -$1.82M | ﹤0.01% | 1414 |
|
|
2021
Q2 | $17.2M | Sell |
162,417
-29,331
| -15% | -$3.1M | 0.04% | 470 |
|
|
2021
Q1 | $5.56M | Sell |
191,748
-23,836
| -11% | -$692K | 0.01% | 778 |
|
|
2020
Q4 | $5.56M | Buy |
215,584
+149,096
| +224% | +$3.85M | 0.02% | 693 |
|
|
2020
Q3 | $2.05M | Buy |
66,488
+47,471
| +250% | +$1.46M | 0.01% | 905 |
|
|
2020
Q2 | $474K | Buy |
+19,017
| New | +$474K | ﹤0.01% | 1445 |
|